Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Inspire Medical Systems (INSP) Shares Repurchased (2025)

Inspire Medical Systems' Shares Repurchased history spans 1 years, with the latest figure at $50.0 million for Q4 2025.

On a quarterly basis, Shares Repurchased changed N/A to $50.0 million in Q4 2025 year-over-year; TTM through Mar 2026 was $100.0 million, a 33.33% increase, with the full-year FY2025 number at $175.0 million, changed N/A from a year prior.
Shares Repurchased hit $50.0 million in Q4 2025 for Inspire Medical Systems, roughly flat from $50.0 million in the prior quarter.
Over the last five years, Shares Repurchased for INSP hit a ceiling of $75.0 million in Q1 2025 and a floor of $50.0 million in Q3 2025.